Systematic review, 2024
How common is PMDD?
PMDD affects 3.2% of women when diagnosed with confirmed criteria and 7.7% when using provisional diagnosis. This means PMDD is less common than some estimates suggest.
What they did
Researchers searched databases for 44 studies measuring how many women have PMDD. They combined the results using statistical methods to get an overall estimate.
What they found
The overall prevalence was 3.2% with confirmed diagnosis and 7.7% with provisional diagnosis. There was high variation between studies. The continent where studies were done affected the results.
What it means for you
PMDD is relatively uncommon. Studies that don't fully confirm the diagnosis tend to report higher rates. A major limitation is that few studies used complete diagnostic criteria in regular community settings.
3.2%
prevalence with confirmed diagnosis
7.7%
prevalence with provisional diagnosis
50,659
total participants
About the study
- Original title
- The prevalence of premenstrual dysphoric disorder: Systematic review and meta-analysis
- Authors
- Reilly TJ, Patel S, Unachukwu IC et al.
- Journal
- Journal of affective disorders
- Year
- 2024
- Study design
- Systematic review
- What was tested
- None
- Open access
- Yes
- Read the paper
- doi.org/10.1016/j.jad.2024.01.066
Original abstract
Background: Premenstrual dysphoric disorder is characterised by symptoms confined to the premenstrual phase of the menstrual cycle. Confirmed diagnosis requires prospective monitoring of symptoms over two cycles, otherwise the diagnosis is provisional. We aimed to measure the point prevalence of premenstrual dysphoric disorder. Methods: We searched for studies of prevalence using MEDLINE, EMBASE, PsycINFO and PubMed. For each study, the total sample size and number of cases were extracted. The prevalence across studies was calculated using random effects meta-analysis with a generalised linear mixed model. Potential sources of heterogeneity were explored by meta-regression and subgroup analyses. Pre-registration was with PROSPERO (CRD42021249249). Results: 44 studies with 48 independent samples met inclusion criteria, consisting of 50,659 participants. The pooled prevalence was 3.2 % (95 % confidence intervals: 1.7 %-5.9 %) for confirmed and 7.7 % (95 % confidence intervals: 5.3 %-11.0 %) for provisional diagnosis. There was high heterogeneity across all studies (I 2 = 99 %). Sources of heterogeneity identified by meta-regression were continent of sample (p 2 = 26 %). Limitations: A small number of included studies used full DSM criteria in community settings. Conclusions: The point prevalence of premenstrual dysphoric disorder using confirmed diagnosis is lower compared with provisional diagnosis. Studies relying on provisional diagnosis are likely to produce artificially high prevalence rates.
Reproduced under CC-BY.
Topics
Related studies
Cohort study, 2026
What genetic factors are linked to premenstrual symptoms?
Systematic review, 2026
How often do mood disorders and PMS or PMDD occur together?
Review, 2024
What are the most effective treatments for PMDD?
Systematic review, 2021
Are there hormone changes that could explain PMDD or depression in women?
Non-randomised trial, 2008
Can the Sheehan Disability Scale measure whether treatments work?
Randomised trial, 2004
Does dosing sertraline continuously or just before the period work better for severe PMS?